SR750
Not Specified (Pain/Inflammation/CNS)
Phase 2Active (First patient enrolled Sep 2024)
Key Facts
Indication
Not Specified (Pain/Inflammation/CNS)
Phase
Phase 2
Status
Active (First patient enrolled Sep 2024)
Company
About SIMR (Australia) Biotech
SIMR Biotech is a clinical-stage biopharma company developing novel drugs for pain, inflammation, and CNS diseases through a patient-data-driven translational platform.
View full company profile